An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) - Adventist HealthCare

Clinical Trial Details

SystHERs Registry

An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Breast Cancer
Study Type: Non-interventional
Phase: Phase IV
Study Start Date: 06/12/2012
Study Completion Date: TBD

This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC). Eligible patients will have an initial metastatic breast cancer diagnosis that has not been previously treated with systemic therapy; patients may be enrolled up to 6 months after the diagnosis. Data will be collected for up to 8 years.

NCT Number
NCT01615068
Principal Investigator(s)
John Wallmark, MD
Sponsor(s)
Genentech, Inc
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.